Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Haluk Ozen

Showing results (61-70 of 75) with videos related to

Pageof 8
Sort By:
Urology|July 11, 2009
Validation of two preoperative Kattan nomograms predicting recurrence after radical prostatectomy for localized prostate cancer in Turkey: a multicenter study of the Uro-oncology SocietySaadettin Y Eskicorapci, Levent Türkeri, Erdem Karabulut, et al.
BJU International|April 17, 2012
Androgen deprivation therapy for volume reduction, lower urinary tract symptom relief and quality of life improvement in patients with prostate cancer: degarelix vs goserelin plus bicalutamideKarol Axcrona, Sirpa Aaltomaa, Carlos Martins da Silva, et al.
Urology Journal|June 10, 2011
Bowel preparation and peri-operative management for radical cystectomy in Turkey: Turkish Urooncology Association multicenter surveyGuven Aslan, Sumer Baltaci, Cag Cal, et al.
European Journal of Cancer (Oxford, England : 1990)|February 4, 2014
Safety of cabazitaxel in senior adults with metastatic castration-resistant prostate cancer: results of the European compassionate-use programmeAxel Heidenreich, Sergio Bracarda, Malcolm Mason, et al.
Urology Journal|July 27, 2022
Oncological Outcomes of Patients with Non-Clear Cell Renal Cell Cancers: Subtypes of Unclassified and Translocation Renal Cell CancersFatih Gokalp, Serdar Celik, Tevfik Sinan Sozen, et al.
Urology Journal|June 12, 2024
Oncological Outcomes of Chromophobe Versus Clear Cell Renal Cell Carcinoma: Results from A Contemporary Turkish Patient CohortTaha Cetin, Serdar Celik, Sinan Sozen, et al.
Archivio Italiano Di Urologia, Andrologia : Organo Ufficiale [Di] Societa Italiana Di Ecografia Urologica E Nefrologica|May 31, 2023
Oncological outcomes of papillary <i>versus</i> clear cell renal cell carcinoma in pT1 and pT2 stage: Results from a contemporary Turkish patient cohortTaha Cetin, Serdar Celik, Sinan Sozen, et al.
Urologia Internationalis|May 5, 2021
Sextant Biopsy-Based Criteria for Clinically Insignificant Prostate Cancer Are Also Valid for the 12-Core Prostate Biopsy Scheme: A Multicenter Study of Urooncology Association, TurkeySerdar Çelik, Fuat Kızılay, Kutsal Yörükoğlu, et al.
The Journal of Urology|July 13, 2010
Is prophylactic breast radiotherapy necessary in all patients with prostate cancer and gynecomastia and/or breast pain?Haluk Ozen, Fadil Akyol, Gokhan Toktas, et al.
International Journal of Clinical Practice|May 11, 2021
How accurate is radiological imaging for perirenal fat and renal vein invasion in renal cell carcinoma?Oktay Ucer, Talha Muezzinoglu, Ender Ozden, et al.
Pageof 8

Showing results (61-70 of 75) with videos related to

Sort By:
Pageof 8
Urology|July 11, 2009
Validation of two preoperative Kattan nomograms predicting recurrence after radical prostatectomy for localized prostate cancer in Turkey: a multicenter study of the Uro-oncology SocietySaadettin Y Eskicorapci, Levent Türkeri, Erdem Karabulut, et al.
BJU International|April 17, 2012
Androgen deprivation therapy for volume reduction, lower urinary tract symptom relief and quality of life improvement in patients with prostate cancer: degarelix vs goserelin plus bicalutamideKarol Axcrona, Sirpa Aaltomaa, Carlos Martins da Silva, et al.
Urology Journal|June 10, 2011
Bowel preparation and peri-operative management for radical cystectomy in Turkey: Turkish Urooncology Association multicenter surveyGuven Aslan, Sumer Baltaci, Cag Cal, et al.
European Journal of Cancer (Oxford, England : 1990)|February 4, 2014
Safety of cabazitaxel in senior adults with metastatic castration-resistant prostate cancer: results of the European compassionate-use programmeAxel Heidenreich, Sergio Bracarda, Malcolm Mason, et al.
Urology Journal|July 27, 2022
Oncological Outcomes of Patients with Non-Clear Cell Renal Cell Cancers: Subtypes of Unclassified and Translocation Renal Cell CancersFatih Gokalp, Serdar Celik, Tevfik Sinan Sozen, et al.
Urology Journal|June 12, 2024
Oncological Outcomes of Chromophobe Versus Clear Cell Renal Cell Carcinoma: Results from A Contemporary Turkish Patient CohortTaha Cetin, Serdar Celik, Sinan Sozen, et al.
Archivio Italiano Di Urologia, Andrologia : Organo Ufficiale [Di] Societa Italiana Di Ecografia Urologica E Nefrologica|May 31, 2023
Oncological outcomes of papillary <i>versus</i> clear cell renal cell carcinoma in pT1 and pT2 stage: Results from a contemporary Turkish patient cohortTaha Cetin, Serdar Celik, Sinan Sozen, et al.
Urologia Internationalis|May 5, 2021
Sextant Biopsy-Based Criteria for Clinically Insignificant Prostate Cancer Are Also Valid for the 12-Core Prostate Biopsy Scheme: A Multicenter Study of Urooncology Association, TurkeySerdar Çelik, Fuat Kızılay, Kutsal Yörükoğlu, et al.
The Journal of Urology|July 13, 2010
Is prophylactic breast radiotherapy necessary in all patients with prostate cancer and gynecomastia and/or breast pain?Haluk Ozen, Fadil Akyol, Gokhan Toktas, et al.
International Journal of Clinical Practice|May 11, 2021
How accurate is radiological imaging for perirenal fat and renal vein invasion in renal cell carcinoma?Oktay Ucer, Talha Muezzinoglu, Ender Ozden, et al.
Pageof 8